×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Chevallard Daniel R.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
LENZLENZ Therapeutics, Inc.Chevallard Daniel R.Chief Financial OfficerMay 14, 2024Buy$15.683,18849,9883,188May 15, 2024, 04:13 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COOFeb 27, 2024Sale$0.733,4052,493102,306Feb 27, 2024, 07:54 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COONov 28, 2023Sale$0.503,7201,86098,822Nov 28, 2023, 07:06 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COOAug 28, 2023Sale$1.453,5125,09295,653Aug 29, 2023, 06:47 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COOMay 25, 2023Sale$1.423,6355,16092,277May 26, 2023, 07:29 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COOFeb 27, 2023Sale$1.683,5996,05189,023Feb 28, 2023, 06:22 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COONov 28, 2022Sale$2.723,5329,60685,733Nov 29, 2022, 05:33 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COOAug 26, 2022Sale$4.023,65514,67982,376Aug 29, 2022, 09:14 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COOMay 26, 2022Sale$1.903,5966,83679,142May 27, 2022, 05:27 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COOFeb 28, 2022Sale$2.783,99811,11275,849Mar 01, 2022, 09:10 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COONov 26, 2021Sale$4.803,25415,62177,283Nov 29, 2021, 07:48 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COONov 29, 2021Sale$4.824,32520,84372,958Nov 29, 2021, 07:48 PM
VIRXViracta Therapeutics, Inc.Chevallard Daniel R.CFO and COOSep 28, 2021Option Exercise$0.9010,0009,00066,760Sep 29, 2021, 06:04 PM
RGLSRegulus Therapeutics Inc.Chevallard Daniel R.Chief Financial OfficerJul 01, 2019Sale$1.312,6693,50077,870Jul 02, 2019, 05:41 PM
RGLSRegulus Therapeutics Inc.Chevallard Daniel R.Chief Financial OfficerMay 15, 2019Sale$1.4110,00014,08980,539May 16, 2019, 05:21 PM
RGLSRegulus Therapeutics Inc.Chevallard Daniel R.Chief Financial OfficerApr 01, 2019Sale$0.983,2533,1929,372Apr 03, 2019, 12:00 AM
RGLSRegulus Therapeutics Inc.Chevallard Daniel R.Chief Financial OfficerFeb 05, 2019Option Exercise$0.9530,00028,50034,578Feb 06, 2019, 04:50 PM
RGLSRegulus Therapeutics Inc.Chevallard Daniel R.Chief Financial OfficerJul 25, 2017Buy$0.9154,94550,00059,415Jul 25, 2017, 06:07 PM